Pathophysiology of GHRH-growth hormone-IGF1 axis in HIV/AIDS.

Item

http://www.wikidata.org/entity/Q38105267

description

article científic

@ca

article scientifique

@fr

articol științific

@ro

articolo scientifico

@it

artigo científico

@gl

artigo científico

@pt

artigo científico

@pt-br

artikel ilmiah

@id

artikull shkencor

@sq

artículo científico

@es

name

Pathophysiology of GHRH-growth hormone-IGF1 axis in HIV/AIDS.

@en

type

Item

label

Pathophysiology of GHRH-growth hormone-IGF1 axis in HIV/AIDS.

@en

prefLabel

Pathophysiology of GHRH-growth hormone-IGF1 axis in HIV/AIDS.

@en

P1476

Pathophysiology of GHRH-growth hormone-IGF1 axis in HIV/AIDS.

@en

P2093

Amrit Bhangoo

http://www.w3.org/2001/XMLSchema#string

Ninad Desai

http://www.w3.org/2001/XMLSchema#string

Shobhit Jain

http://www.w3.org/2001/XMLSchema#string

P2860

Abdominal visceral fat and fasting insulin are important predictors of 24-hour GH release independent of age, gender, and other physiological factors.

Assessment of growth hormone dynamics in human immunodeficiency virus-related lipodystrophy.

Effects of insulin-like growth factor (IGF)-I/IGF-binding protein-3 treatment on glucose metabolism and fat distribution in human immunodeficiency virus-infected patients with abdominal obesity and insulin resistance.

Abacavir substitution for nucleoside analogs in patients with HIV lipoatrophy: a randomized trial.

Reduction in visceral adiposity is associated with an improved metabolic profile in HIV-infected patients receiving tesamorelin.

Switching effective antiretroviral therapy: a review.

Metabolic function and the prevalence of lipodystrophy in a population of HIV-infected African subjects receiving highly active antiretroviral therapy

Peripheral and visceral fat changes following a treatment switch to a non-thymidine analogue or a nucleoside-sparing regimen in HIV-infected subjects with peripheral lipoatrophy: results of ACTG A5110.

Responsiveness of muscle protein synthesis to growth hormone administration in HIV-infected individuals declines with severity of disease

Different growth hormone sensitivity of target tissues and growth hormone response to glucose in HIV-infected patients with and without lipodystrophy.

P2888

s11154-013-9245-9

P304

113-118

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S11154-013-9245-9

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2013-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1025859223

http://www.w3.org/2001/XMLSchema#string

P698

23657561

http://www.w3.org/2001/XMLSchema#string

P921

pathophysiology